Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
- PMID: 15448342
- DOI: 10.1099/vir.0.80035-0
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Abstract
An important characteristic of the E6 proteins derived from cancer-associated human papillomaviruses (HPVs) is their ability to target cellular proteins for ubiquitin-mediated degradation. Degradation of the p53 tumour suppressor protein by E6 is known to involve the cellular ubiquitin ligase, E6-AP; however, it is presently not known how E6 targets the Drosophila discs large (Dlg) tumour suppressor and the membrane-associated guanylate kinase inverted (MAGI) family of proteins for degradation. By using an in vitro E6-AP immunodepletion assay, these targets were tested for degradation in a E6-AP-dependent manner. The data showed clearly that E6 can direct the degradation of Dlg and the MAGI family of proteins in the absence of E6-AP in this in vitro system. These results provide compelling evidence for the role of E6-associated ubiquitin ligases other than E6-AP in the degradation of certain E6 targets.
Similar articles
-
HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.Oncogene. 2004 Oct 21;23(49):8033-9. doi: 10.1038/sj.onc.1207977. Oncogene. 2004. PMID: 15378012
-
Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.J Mol Biol. 2004 Jan 23;335(4):971-85. doi: 10.1016/j.jmb.2003.10.079. J Mol Biol. 2004. PMID: 14698292
-
HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.Oncogene. 2000 Feb 10;19(6):719-25. doi: 10.1038/sj.onc.1203374. Oncogene. 2000. PMID: 10698489
-
Mechanism of HPV E6 proteins in cellular transformation.Semin Cancer Biol. 1996 Dec;7(6):317-26. doi: 10.1006/scbi.1996.0041. Semin Cancer Biol. 1996. PMID: 9284524 Review.
-
Structure and function of the papillomavirus E6 protein and its interacting proteins.Front Biosci. 2008 Jan 1;13:121-34. doi: 10.2741/2664. Front Biosci. 2008. PMID: 17981532 Review.
Cited by
-
Identification and characterization of small molecule human papillomavirus E6 inhibitors.ACS Chem Biol. 2014 Jul 18;9(7):1603-12. doi: 10.1021/cb500229d. Epub 2014 Jun 2. ACS Chem Biol. 2014. PMID: 24854633 Free PMC article.
-
In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management.Pharmaceuticals (Basel). 2021 Jul 29;14(8):741. doi: 10.3390/ph14080741. Pharmaceuticals (Basel). 2021. PMID: 34451838 Free PMC article. Review.
-
Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?Tumour Virus Res. 2025 Jun;19:200311. doi: 10.1016/j.tvr.2024.200311. Epub 2024 Dec 27. Tumour Virus Res. 2025. PMID: 39733972 Free PMC article. Review.
-
Human papillomavirus E6 and E7: What remains?Tumour Virus Res. 2021 Jun;11:200213. doi: 10.1016/j.tvr.2021.200213. Epub 2021 Feb 8. Tumour Virus Res. 2021. PMID: 33716206 Free PMC article. Review.
-
PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.J Virol. 2007 Apr;81(8):4080-90. doi: 10.1128/JVI.02545-06. Epub 2007 Feb 7. J Virol. 2007. PMID: 17287269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous